![Han Jung](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Han Jung
Corporate Officer/Principal en Korean Institute of Certified Public Accountants .
Cargos activos de Han Jung
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Korean Institute of Certified Public Accountants | Corporate Officer/Principal | - | - |
Historial de carrera de Han Jung
Antiguos cargos conocidos de Han Jung.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Glycostem Therapeutics BV
![]() Glycostem Therapeutics BV BiotechnologyHealth Technology Glycostem Therapeutics BV operates as a life science company which develops cellular immunotherapy and production technology platforms. It develops cellular immunotherapeutic for the treatment of leukemia, lymphomas, and other forms of cancer. The firm provides Prototype NK-cell and NK-cell progenitor cell products for clinical evaluations and intervention studies; and GBGM, a cell survival and minimal cellular delineation in expansion and differentiation experiments. The company was founded by Dirk Groenewegen and Jan van der Hoeven in 2007 and is headquartered in Oss, the Netherlands. | Director/Miembro de la Junta | - | - |
Estadísticas
Internacional
Países Bajos | 2 |
Corea del Sur | 2 |
Operativa
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Glycostem Therapeutics BV
![]() Glycostem Therapeutics BV BiotechnologyHealth Technology Glycostem Therapeutics BV operates as a life science company which develops cellular immunotherapy and production technology platforms. It develops cellular immunotherapeutic for the treatment of leukemia, lymphomas, and other forms of cancer. The firm provides Prototype NK-cell and NK-cell progenitor cell products for clinical evaluations and intervention studies; and GBGM, a cell survival and minimal cellular delineation in expansion and differentiation experiments. The company was founded by Dirk Groenewegen and Jan van der Hoeven in 2007 and is headquartered in Oss, the Netherlands. | Health Technology |
Korean Institute of Certified Public Accountants |
- Bolsa de valores
- Insiders
- Han Jung
- Experiencia